Involvement of vascular endothelial nitric oxide synthase in development of experimental diabetic nephropathy in rats

Molecular and Cellular Biochemistry

Volumn 354, Issue 1-2, 2011, Pages 57-66

  Arya, Atul ^a   Yadav, Harlokesh Naryan ^a   Sharma, P L ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Caveolin; Diabetic nephropathy; eNOS; Nitric oxide

Indexed keywords

ARGININE; CAVEOLIN; CHOLESTEROL; COLLAGEN; CREATININE; DAIDZEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRITE; PROTEIN; SODIUM NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GLUCOSE BLOOD LEVEL; KIDNEY CORTEX; KIDNEY MASS; MALE; NONHUMAN; PROTEIN URINE LEVEL; RAT; UREA NITROGEN BLOOD LEVEL; URINE VOLUME;

ANIMALS; ARGININE; BLOOD GLUCOSE; BLOOD UREA NITROGEN; BODY WEIGHT; CAVEOLIN 1; CHOLESTEROL; COLLAGEN; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DIETARY FATS; ENDOTHELIUM, VASCULAR; ISOFLAVONES; KIDNEY; MALE; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; ORGAN SIZE; PROTEINURIA; RATS; RATS, WISTAR; SODIUM NITRITE; URINE;

RATTUS;

EID: 79959777296     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0805-6     Document Type: Article

References (43)

1. Ichinose K, Kawasaki E, Eguchi K (2007) Recent advancements of understanding pathogenesis of Type 1 diabetes and potential relevance to diabetic nephropathy. Am J Nephrol 27:554-564 (Pubitemid 350014942)
2. Marshall SM (2004) Recent advances in diabetic nephropathy. Clin Med 3:277-282
3. Prabhakar S, Starnes J, Shi S, Lonis B, Tran R (2007) Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production. J Am Soc Nephrol 18:2945-2952 (Pubitemid 350058402)
4. Vaishya R, Singh J, Lal H (2008) Effect of irbesartan on streptozotocin-induced diabetic nephropathy: an interventionary study. Indian J Clin Biochem 23:195-197
5. Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, Chugh S, Danesh FR (2008) Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med 233:4-11
6. Onozato ML, Tojo A (2005) Role of NADPH oxidase in hypertension and diabetic nephropathy. Curr Hypertens Rev 1:15-20
7. Tomlinson DR (1999) Mitogen-activated protein kinases as glucose transducers for diabetic complications. Diabetologia 42:1271-1281
8. Navarro-Gonzalez JF, Mora-Fernandez C (2008) The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 19:433-442 (Pubitemid 351355386)
9. Dronavalli S, Duka I, Babris GL (2008) The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab 4:444-452
10. Brewster UC, Setaro JF, Perazella MA (2003) The renin angiotensin aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states. Am J Med Sci 326:15-24 (Pubitemid 36870293)
11. Anderson S (1994) Relevance of single nephron studies to human glomerular function. Kidney Int 45:384-389
12. Wiecek A, Chudek J, Kokot F (2003) Role of angiotensin II in progression of diabetic nephropathy-therapeutic implications. Nephrol Dial Transpl 8:v16-v20 (Pubitemid 36896442)
13. Hilger KF, Veelken R (2005) Type 2 diabetic nephropathy: never too early to treat? J Am Soc Nephrol 16:574-575
14. Sedding DG, Braun-Dullaeus RC (2006) Caveolin-1: dual role for proliferation of vascular smooth muscle cells. Trends Cardiovasc Med 1:50-55 (Pubitemid 43214526)
15. Razani B, Wang XB, Engelman JA, Battista M, Lagaud G, Zhang XL, Kneitz B, Hou H, Christ GJ, Edelmann W, Lisanti MP (2002) Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol Cell Biol 22:2329-2344 (Pubitemid 34224637)
16. Hardin CD, Vallejo J (2006) Caveolins in vascular smooth muscle: form organizing function. Cardiovasc Res 69:808-815 (Pubitemid 43227979)
17. Frank PG, Woodman SE, Park DS, Lisanti MP (2003) Caveolin, caveolae, and endothelial cell function. Arterioscler Thromb Vasc Biol 23:1161-1168 (Pubitemid 36871269)
18. Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G, Sessa WC (2000) In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med 6:1362-1367
19. Feron O, Dessy C, Moniotte S, Desager JP, Balligand JL (1999) Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest 103:897-905 (Pubitemid 29152636)
20. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene disrupted mice. Science 293:2449-2452 (Pubitemid 32917325)
21. Escandon JC, Cipolla M (2001) Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 22:36-52
22. Ulker S, McKeown P, Bayraktutan U (2003) Vitamins reverse endothelial dysfunction through regulation of eNOS and NADPH oxidase activities. Hypertension 41:534-541
23. Lott JA, Turner K (1975) Evaluation of Trinder's glucose oxidase method for measuring glucose in serum and urine. Clin Chem 21:1754-1760
24. Jamall IS, Finelli VN, Que Hee SS (1981) A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem 112:70-75
25. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475
26. Srinivasan K, Viswanad B, Lydia Asrat, Kaul CL, Ramarao P (2005) Combination of high-fat diet-fed, low-dose streptozotocintreated rat. A model for type 2 diabetes and pharmacological screening. Pharmacol Res 52:313-320
27. Shah DI, Singh M (2006) Inhibition of protein tyrosin phosphatase improves vascular endothelial dysfunction. Vasc Pharmacol 44:177-182 (Pubitemid 43183666)
28. Jindal S, Singh M, Balakumar P (2007) Effect of bis (maltolato) oxovanadium (BMOV) in uric acid and sodium arsenite-induced vascular endothelial dysfunction in rats. Int J Cardiol 128:383-391
29. Zhao HJ, Wang S, Cheng H, Zhang Z, Takahashi T, Fogo AB, Breyer MD, Harris RC (2006) Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol 17:2664-2669 (Pubitemid 44484656)
30. Fujisawa G, Okada K, Muto S, Futija N, Itabashi N, Kusano E, Ishibashi S (2004) Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats. Kidney int 66(4):1493-1502 (Pubitemid 39298382)
31. Sinuani I, Averbukh Z, Gitelman I, Rapoport MJ, Sandbank J, Albeck M, Sredni B, Weissgarten J (2006) Mesangial cells initiate compensatory renal tubular hypertrophy via IL-10-induced TGF-beta secretion: effect of the immunomodulator AS101 on this process. Am J Physiol Renal Physiol 291:F384-F394 (Pubitemid 44148129)
32. Ahmad J (2008) Renin angiotensin system blockade in diabetic nephropathy. Diabetes and metabolic syndrome. Clin Res Rev 2:135-158
33. Patzak A, Lai E, Persson PB, Persson AE (2005) Angiotensin IInitric oxide interaction in glomerular arterioles. Clin Exp Pharmacol Physiol 32:410-414 (Pubitemid 40780267)
34. Schricker K, Kurtz A (1993) Liberators of NO exert a dual effect on renin secretion from isolated mouse renal juxtaglomerular cells. Am J Physiol 265:F180-F186 (Pubitemid 23270334)
35. Xiao-Rui He, Suzanne G, Greenberg Josie P, Jurgen B (1995) Effect of nitric oxide in renin secretion II. Studies in the perfused juxtaglomerular apparatus. Am J Physiol 268:F953-F959
36. Greenberg SG, He XR, Schnermann JB, Briggs JP (1995) Effect of nitric oxide on renin secretion I. Studies in isolated juxtaglomerular granular cells. Am J Physiol 268:F948-F952
37. Laursen JB, Boesgaard S, Trautner S, Rubin I, Poulsen HE, Aldershvile J (2001) Endothelium-dependent vasorelaxation is inhibited by in vivo depletion of vascular thiol levels: role of endothelial nitric oxide synthase. Free Radic Res 35:387-394 (Pubitemid 32894357)
38. Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS (2002) Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int 61:186-194 (Pubitemid 34075146)
39. Nakagawa T, Sato W, Glushakova W, Heinig M, Clarke T, Thompson M (2007) Diabetic endothelial nitric oxide synthase knock out mice develops advanced diabetic nephropathy. J Am Soc Nephrol 18:539-550 (Pubitemid 46193319)
40. Chini B, Parenti M (2004) G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there? J Mol Endocrinol 32:325-338
41. Sessa WC (2005) Regulation of endothelial derived nitric oxide in health and disease. Mem Inst Oswaldo Cruz 100:15-18
42. Woodman OL, Missen MA, Boujaoude M (2004) Daidzein and 17 betaestradiol enhance nitric oxide synthase activity associated with an increase in calmodulin and a decrease in caveolin-1. J Cardiovasc Pharmacol 44:155-163 (Pubitemid 38982157)
43. Peterson TE, Kleppe LS, Caplice NM, Pan S, Mueske CS, Simari RD (1999) The regulation of caveolin expression and localization by serum and heparin in vascular smooth muscle cells. Communication 265:722-727